167 related articles for article (PubMed ID: 26262435)
1. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
Ryödi E; Metso S; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A
J Clin Endocrinol Metab; 2015 Oct; 100(10):3710-7. PubMed ID: 26262435
[TBL] [Abstract][Full Text] [Related]
2. Increased cancer incidence after radioiodine treatment for hyperthyroidism.
Metso S; Auvinen A; Huhtala H; Salmi J; Oksala H; Jaatinen P
Cancer; 2007 May; 109(10):1972-9. PubMed ID: 17393376
[TBL] [Abstract][Full Text] [Related]
3. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2190-6. PubMed ID: 17374710
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy.
Ryödi E; Metso S; Huhtala H; Välimäki M; Auvinen A; Jaatinen P
Thyroid; 2018 Sep; 28(9):1111-1120. PubMed ID: 29882483
[TBL] [Abstract][Full Text] [Related]
5. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism.
Metso S; Auvinen A; Salmi J; Huhtala H; Jaatinen P
Clin Endocrinol (Oxf); 2008 Mar; 68(3):450-7. PubMed ID: 17941909
[TBL] [Abstract][Full Text] [Related]
6. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism.
Kitahara CM; Preston DL; Sosa JA; Berrington de Gonzalez A
JAMA Netw Open; 2020 Jul; 3(7):e209660. PubMed ID: 32701159
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular morbidity and mortality in surgically treated hyperthyroidism - a nation-wide cohort study with a long-term follow-up.
Ryödi E; Salmi J; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A; Metso S
Clin Endocrinol (Oxf); 2014 May; 80(5):743-50. PubMed ID: 24304446
[TBL] [Abstract][Full Text] [Related]
9. Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis.
Shim SR; Kitahara CM; Cha ES; Kim SJ; Bang YJ; Lee WJ
JAMA Netw Open; 2021 Sep; 4(9):e2125072. PubMed ID: 34533571
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
11. MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.
Peng CC; Lin YJ; Lee SY; Lin SM; Han C; Loh CH; Huang HK; Pearce EN
JAMA Netw Open; 2024 Mar; 7(3):e240904. PubMed ID: 38436957
[TBL] [Abstract][Full Text] [Related]
12. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
Ron E; Doody MM; Becker DV; Brill AB; Curtis RE; Goldman MB; Harris BS; Hoffman DA; McConahey WM; Maxon HR; Preston-Martin S; Warshauer ME; Wong FL; Boice JD
JAMA; 1998 Jul 22-29; 280(4):347-55. PubMed ID: 9686552
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
14. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
15. Long term follow-up of treated hyperthyroid and hypothyroid patients.
Leese GP; Jung RT; Scott A; Waugh N; Browning MC
Health Bull (Edinb); 1993 May; 51(3):177-83. PubMed ID: 8325778
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine therapy increases the risk of cerebrovascular events in hyperthyroid and euthyroid patients.
la Cour JL; Jensen LT; Vej-Hansen A; Nygaard B
Eur J Endocrinol; 2015 Jun; 172(6):771-8. PubMed ID: 25920711
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study.
Franklyn JA; Maisonneuve P; Sheppard M; Betteridge J; Boyle P
Lancet; 1999 Jun; 353(9170):2111-5. PubMed ID: 10382695
[TBL] [Abstract][Full Text] [Related]
18. Failure of radioactive iodine in the treatment of hyperthyroidism.
Schneider DF; Sonderman PE; Jones MF; Ojomo KA; Chen H; Jaume JC; Elson DF; Perlman SB; Sippel RS
Ann Surg Oncol; 2014 Dec; 21(13):4174-80. PubMed ID: 25001092
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer following iodine-131 therapy for hyperthyroidism.
Hoffman DA; McConahey WM
J Natl Cancer Inst; 1983 Jan; 70(1):63-7. PubMed ID: 6571923
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta-analysis.
Liu X; Wong CKH; Wu T; Chan WWL; Woo YC; Lam CLK; Lang BHH
World J Surg; 2024 Feb; 48(2):393-407. PubMed ID: 38686801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
